About this trial
To compare the efficacy and safety of intratracheal deep intubation with traditional intubation in endoscopic submucosal dissection for early esophageal cancer in the cervical esophagus, and to follow up and assess their short-term clinical outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
The lesions mainly involve superficial esophageal squamous cell carcinoma or high-grade intraepithelial neoplasia (HGIN) in the cervical esophagus;
There is no evidence of regional lymph node or distant metastasis on endoscopic ultrasound (EUS) or CT/MRI imaging;
Participants have a thorough understanding of this study and voluntarily sign the informed consent form.
Disqualifiers
1. Patients who have received radiotherapy or chemotherapy before endoscopic submucosal dissection surgery; 2. Patients with severe comorbidities who are not suitable for endoscopic submucosal dissection surgery.
Trial design
Parallel
Treatments tested in this trial
Deeper endotracheal intubation
Procedure/SurgeryAfter general anesthesia, endotracheal intubation was conducted using an ultrafine endoscope (GIF-XP260NS, Olympus Corp., Japan), which allows observation of the exact position and avoids blindness caused by laryngoscopy. To prevent balloon compression of the CE after inflating, the endotracheal intubation tube was inserted above the tracheal carina, roughly the upper thoracic esophagus.
Treatment groups
Trial outcomes
Primary outcomes
the rate of complete resection and postoperative stricture
Secondary outcomes
ESD procedural time and other procedure-related complications
Sponsors and contacts
Click on the lead sponsor to view all of their trials.